Similar articles

• [Off-label-use in dermatology].

  Sterry W. Sterry W. J Dtsch Dermatol Ges. 2009 Nov;7(11):931-2. doi: 10.1111/j.1610-0387.2009.07276.x. J Dtsch Dermatol Ges. 2009. PMID: 19909390 German. No abstract available.
• HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

  Chelidze K, Thomas C, Chang AY, Freeman EE. Chelidze K, et al. Am J Clin Dermatol. 2019 Jun;20(3):423-442. doi: 10.1007/s40257-019-00422-0. Am J Clin Dermatol. 2019. PMID: 30806959 Free PMC article. Review.
• HIV and AIDS in inpatient dermatology. Approach to the consultation.

  Finkelstein M, Berman B. Finkelstein M, et al. Dermatol Clin. 2000 Jul;18(3):509-20, x. doi: 10.1016/s0733-8635(05)70198-4. Dermatol Clin. 2000. PMID: 10943545 Review.
• [Guidelines for therapy with fumaric acid ester].

  Mrowietz U. Mrowietz U. Hautarzt. 2001 Oct;52(10):862-4. doi: 10.1007/s001050170047. Hautarzt. 2001. PMID: 17690813 German. No abstract available.
• AIDS-related Kaposi sarcoma: the role of local therapy for a systemic disease.

  Dezube BJ. Dezube BJ. Arch Dermatol. 2000 Dec;136(12):1554-6. doi: 10.1001/archderm.136.12.1554. Arch Dermatol. 2000. PMID: 11115173 No abstract available.